| Dr Robert G Carlile, MD | |
|
1380 Lusitana St #1004, Honolulu, HI 96813-2461 | |
| (808) 523-9400 | |
| (808) 526-3080 |
| Full Name | Dr Robert G Carlile |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 37 Years |
| Location | 1380 Lusitana St #1004, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508821794 | NPI | - | NPPES |
| 193017 | Other | HI | HMA |
| 5379671 | Other | HI | UHA |
| B94546 | Other | HI | HMSA |
| 07270903 | Medicaid | HI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD7799 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Castle | Kailua, HI | Hospital |
| The Queens Medical Center | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Castle Medical Center | 6608762778 | 71 |
News Archive
Morphotek, Inc. announced today the issuance of United States Patent 6,737,268 covering the generation of genetically enhanced therapeutic antigens.
SANE Australia has revealed data that shows that nearly 90% of patients with mental illness also suffer from chronic ailments like diabetes, heart disease etc.
Shire plc, the global specialty biopharmaceutical company, announces that it has settled all pending litigation with Sandoz, Inc. ("Sandoz") in connection with Sandoz's Abbreviated New Drug Application ("ANDA") and its attempt to market generic versions of Shire's ADDERALL XR(R) (mixed amphetamine salts) for the treatment of Attention Deficit Hyperactivity Disorder.
Researchers at Yale School of Medicine have developed a new animal model for studying hemophilia A, with the goal of eventually treating people with the disorder.
› Verified 9 days ago
| Entity Name | Castle Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316937691 PECOS PAC ID: 6608762778 Enrollment ID: O20040225000693 |
News Archive
Morphotek, Inc. announced today the issuance of United States Patent 6,737,268 covering the generation of genetically enhanced therapeutic antigens.
SANE Australia has revealed data that shows that nearly 90% of patients with mental illness also suffer from chronic ailments like diabetes, heart disease etc.
Shire plc, the global specialty biopharmaceutical company, announces that it has settled all pending litigation with Sandoz, Inc. ("Sandoz") in connection with Sandoz's Abbreviated New Drug Application ("ANDA") and its attempt to market generic versions of Shire's ADDERALL XR(R) (mixed amphetamine salts) for the treatment of Attention Deficit Hyperactivity Disorder.
Researchers at Yale School of Medicine have developed a new animal model for studying hemophilia A, with the goal of eventually treating people with the disorder.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert G Carlile, MD 1380 Lusitana St #1004, Honolulu, HI 96813-2461 Ph: (808) 523-9400 | Dr Robert G Carlile, MD 1380 Lusitana St #1004, Honolulu, HI 96813-2461 Ph: (808) 523-9400 |
News Archive
Morphotek, Inc. announced today the issuance of United States Patent 6,737,268 covering the generation of genetically enhanced therapeutic antigens.
SANE Australia has revealed data that shows that nearly 90% of patients with mental illness also suffer from chronic ailments like diabetes, heart disease etc.
Shire plc, the global specialty biopharmaceutical company, announces that it has settled all pending litigation with Sandoz, Inc. ("Sandoz") in connection with Sandoz's Abbreviated New Drug Application ("ANDA") and its attempt to market generic versions of Shire's ADDERALL XR(R) (mixed amphetamine salts) for the treatment of Attention Deficit Hyperactivity Disorder.
Researchers at Yale School of Medicine have developed a new animal model for studying hemophilia A, with the goal of eventually treating people with the disorder.
› Verified 9 days ago
Dr. David Shu- An Chou, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1029 Kapahulu Ave, Suite 306, Honolulu, HI 96816 Phone: 808-218-7858 Fax: 808-218-7859 | |
Joseph Sterbis, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Urology Clinic, Honolulu, HI 96822 Phone: 808-433-2972 | |
Dr. Kent K. Teruya, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1329 Lusitana St Ste 508, Honolulu, HI 96813 Phone: 808-531-1511 | |
Sergei Tikhonenkov, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1329 Lusitana St, Suite 602, Honolulu, HI 96813 Phone: 808-522-5055 | |
Ann M Aspera, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
William Joseph Yarbrough Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1329 Lusitana St, Suite 602, Honolulu, HI 96813 Phone: 808-522-5055 Fax: 808-524-6306 | |
Dr. David C. Wei, MD, FACS Urology Medicare: Medicare Enrolled Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 Fax: 808-432-8241 |